NYSE American · INFUHealthcareSurgical Instruments

InfuSystem Holdings, Inc. (INFU)

$12.80−7.51%
Close Nov 3, 2026 · split-adjusted
Nov 3, 2026$12.80▲ 23.08% in range
Nov 3, 2025Low $7.42 · High $14.45Nov 3, 2026
What changed · written from our data
As of Nov 3, 2026

InfuSystem Holdings closed at $12.80 on Nov 3, down 7.51%, 11.4% below its 52-week closing high. Volume of 249.4K shares was 2.10× its 20-day average (well above normal).

Split-adjusted performance: -5.1% over one month, +20.5% over six months, +23.6% over one year.

In the quarter ended Jun 30, 2026, revenue was $36.93M, up 2.6% from a year earlier, with a net margin of 8.7%.

Short interest was 813.4K shares at the Oct 15 settlement, down 5.9% from the prior report (4.9% of float, 7.6 days to cover).

Market cap$254.9M19.9M shares
Revenue · quarter$36.9M+2.6% YoY
Diluted EPS$0.15+25.0% YoY
P/E · TTM29.8×P/S 1.8×
Net margin8.7%Gross 58.0%
Dividend yieldNone
52-week range7.42 – 14.45−11.4% from high
Volume249.4K2.10× 20-day avg
Volatility · 60d29.9%Annualised
Short % of float4.9%7.6 days to cover
Net cash-$19.5MCash $964.0K
Next earnings—Not scheduled
Split-adjusted performance
1W −9.4%1M −5.1%3M +5.3%6M +20.5%YTD +42.7%1Y +23.6%3Y +30.3%5Y −14.5%

Earnings reactions

History →

No reported quarters with price history yet.

Rank within Surgical Instruments

Percentile among 110 companies (100 = best)

6-month momentum71
Revenue growth32
Net margin74
Value (low P/E)43
Size47

Industry medians: 6-month return −9.7%, revenue growth +8.9%, net margin −8.2%, P/E 28.1×.

Short interest

Details →
Shares short813.4K−5.9% vs prior
Days to cover7.6Settled Oct 15
% of float4.9%
Short vol. 10d49.3%of daily volume

Closest peers by size in Surgical Instruments

CompanyPriceToday6MRev. growthNet marginP/EMkt cap
INFUInfuSystem Holdings$12.80−7.51%+20.5%+2.6%8.7%29.8$254.9M
PROFProfound Medical$6.99+3.86%−3.9%+12.3%−384.2%—$255.4MCompare
ANIKAnika Therapeutics$19.45+0.21%+30.1%+15.6%10.1%—$260.3MCompare
OSUROraSure Technologies$3.53+2.17%+17.7%−1.9%20.4%—$243.5MCompare
TMCITreace Medical Concepts$4.28+0.23%+127.7%−4.2%−35.0%—$278.3MCompare
UTMDUtah Medical Products$70.02−0.75%+8.0%−14.3%31.5%21.2$222.3MCompare
TLSITriSalus Life Sciences$3.48−4.13%−24.5%+1.7%−80.5%—$214.3MCompare
CLPTClearPoint Neuro$9.71−2.41%−12.5%+36.3%−61.8%—$311.2MCompare
MOBIMobia Medical$9.97−0.99%——−155.8%—$331.9MCompare

News about InfuSystem Holdings

All news →

No recent articles focused on InfuSystem Holdings.

Quick answers

What does InfuSystem Holdings do?
InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions.
What is INFU's market cap?
$254.94M, based on the Nov 3 close of $12.80.
What is INFU's P/E ratio?
29.8× trailing-twelve-month earnings of $8.54M.
Does InfuSystem Holdings pay a dividend?
No regular cash dividend has been paid in the last year.
How much of INFU is sold short?
813.4K shares, 4.9% of float, as of Oct 15, 2026.
What sector is INFU in?
Healthcare, in the Surgical Instruments industry.

About InfuSystem Holdings

InfuSystems Holdings Inc is a health care service provider, facilitating outpatient care for durable medical equipment manufacturers and health care providers. The company's services are provided under two-reportable segments: Patient Services and Device Solutions. Maximum revenue is generated from its Patient Services segment, which provides Durable Medical Equipment (DME) and treatment consumables, handles order and delivery logistics, provides 24/7 nursing support relating to the provided equipment, assumes responsibility for third-party payer Durable Medical Equipment billing, and handles biomedical services for the Durable Medical Equipment. The Device Solutions segment includes equipment rental and sales, consumable sales, and biomedical support services.

HQ: Rochester Hills, MI473 employeesListed Dec 22, 1992infusystem.com

Sources: Massive / Polygon daily aggregates (split-adjusted) · SEC filings via Massive · FINRA settlements via Massive · Financial Modeling Prep. Figures are dated where shown; research is informational, not investment advice. Methodology